CytoDyn Inc (OTCQB:CYDY) CEO Nader Pourhassan tells Proactive it revealed patient safety data from a Phase 2 coronavirus trial of its drug leronlimab, which he says, showed significantly lower adverse events than a placebo. Pourhassan explains why he believes the…

Find more lectures and answers to COVID-19 related questions on DrBeen.Com DrBeen team and #koolbeens are super excited to have Dr. Pourhassan with us today. We will discuss Leronlimab with Dr. Pourhassan. #koolbeens have asked a tons of questions to…